Director, Scientific Business Development

Responsibilities Lead the scientific and business development strategy connecting our BBBo-FUS platform with the neuro‑biotech ecosystem. Map and analyze potential of FUS modalities together with adjacent biotech innovations. Evaluate convergent CNS technologies: biologics, gene and cell therapies, biomarkers, diagnostics. Lead scientific due diligence in the context of licensing and/or partnerships. Translate discoveries into preclinical and support early clinical development roadmaps. (Pre‑Clinical/Phase 1‑2) Engage KOLs, academic partners, and advisory boards to shape technology strategy as needed. Advise internal R&D, Clinical, and Regulatory teams on convergence and combination approaches. Lead point of contact on strategic partnerships, co‑development deals, licensing opportunities. Lead IP and freedom‑to‑operate assessment; support negotiation of term sheets and agreements. Manage deal pipeline, CRM tracking, and executive reporting. Develop, manage and present BD strategies and recommendations to leadership. Represent the company at key conferences and partnering meetings. Coordinate cross‑functional deal diligence and integration. Requirements PhD in Neuroscience, Biomedical Engineering, Molecular Biology, or related field (required) MBA or equivalent business training/experience (preferred); MD or MD/PhD also considered 7–10 years in biotech/pharma/medtech, with 3–5 years in translational R&D (neuro‑oncology, CNS delivery, or molecular biotech) 2–3 years in BD, licensing, or partnerships involving CNS assets or platform technologies Proven success in closing licensing or co‑development deals Strong understanding of CNS drug delivery and BBB challenges Knowledge of biologics, gene/cell therapy, and molecular diagnostics Familiarity with FDA/EMA regulatory pathways for combination products IP and deal‑structuring acumen (milestones, royalties, equity) #J-18808-Ljbffr Jobtailor